Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Spinal Diseases × Melphalan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 25 Precursor Cell Lymphoblastic Leukemia-Lymphoma 19 Lymphoma 19 Leukemia, Myeloid, Acute 16 Myelodysplastic Syndromes 15 Lymphoma, Non-Hodgkin 14 Leukemia 12 Neuroblastoma 11 Neoplasms, Plasma Cell 11 Leukemia, Lymphocytic, Chronic, B-Cell 11 Hodgkin Disease 9 Lymphoma, Large B-Cell, Diffuse 8 Recurrence 7 Melanoma 7 Sarcoma 6 Ovarian Neoplasms 6 Myeloproliferative Disorders 6 Lymphoma, Mantle-Cell 6 Lymphoma, Large-Cell, Immunoblastic 6 Lymphoma, Follicular 6 Hematologic Neoplasms 6 Burkitt Lymphoma 6 Sarcoma, Ewing 5 Neoplasm Metastasis 5 Medulloblastoma 5 Lymphoma, B-Cell, Marginal Zone 5 Liver Neoplasms 5 Wilms Tumor 4 Rhabdomyosarcoma 4 Retinoblastoma 4

Interventions

Melphalan 1 Infusions, Intra-Arterial 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01637766 2020-08-03

SIAC

Weill Medical College of Cornell University

Phase 1 Completed

Spinal Cord Compression, Spinal Cord Neoplasms, Spinal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡